These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27444769)

  • 1. Sugammadex.
    Golembiewski J
    J Perianesth Nurs; 2016 Aug; 31(4):354-7. PubMed ID: 27444769
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex (Bridion) for rapid reversal of neuromuscular blockade.
    Med Lett Drugs Ther; 2016 Aug; 58(1502):112-3. PubMed ID: 27552208
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.
    Ren WH; Jahr JS
    Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia.
    Murata T; Kubodera T; Ohbayashi M; Murase K; Adachi YU; Matsuda N
    Can J Anaesth; 2013 May; 60(5):508-9. PubMed ID: 23460187
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
    Ploeger BA; Smeets J; Strougo A; Drenth HJ; Ruigt G; Houwing N; Danhof M
    Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 9. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugammadex: the good, the bad and the ugly.
    Vercauteren M
    Acta Anaesthesiol Belg; 2013; 64(2):39-40. PubMed ID: 24191524
    [No Abstract]   [Full Text] [Related]  

  • 11. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
    Hogg RM; Mirakhur RK
    Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugammadex: an opportunity to change the practice of anesthesiology?
    Miller RD
    Anesth Analg; 2007 Mar; 104(3):477-8. PubMed ID: 17312188
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sugammadex: a new approach to the use of neuromuscular blockers].
    Alvarez-Gómez JA; Veiga-Ruiz G
    Rev Esp Anestesiol Reanim; 2011 Jun; 58 Suppl 2():20-3. PubMed ID: 21916086
    [No Abstract]   [Full Text] [Related]  

  • 14. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex: cyclodextrins, development of selective binding agents, pharmacology, clinical development, and future directions.
    Akha AS; Rosa J; Jahr JS; Li A; Kiai K
    Anesthesiol Clin; 2010 Dec; 28(4):691-708. PubMed ID: 21074746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex as rescue therapy for residual neuromuscular blockade in the intensive care unit.
    Carron M; Baratto F; Pettenuzzo T; Ori C
    Can J Anaesth; 2016 Dec; 63(12):1384-1385. PubMed ID: 27646527
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex--a short review and clinical recommendations for the cardiac anesthesiologist.
    Hemmerling TM; Zaouter C; Geldner G; Nauheimer D
    Ann Card Anaesth; 2010; 13(3):206-16. PubMed ID: 20826961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can sugammadex save the situation of a "no intubation, no ventilation" patient?].
    Gutiérrez García R; Abad Gurumeta A; Cúbek Quevedo D; Jiménez Sánchez C
    Rev Esp Anestesiol Reanim; 2013; 60(7):411-2. PubMed ID: 23083977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.